Stewart WF, Lipton RB, Celentano DD, Reed ML (1992) Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA 267(1):64–69
Article
CAS
PubMed
Google Scholar
Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M (2001) Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache 41(7):646–657
Article
CAS
PubMed
Google Scholar
Gobel H, Petersen-Braun M, Soyka D (1994) The epidemiology of headache in Germany: a nationwide survey of a representative sample on the basis of the headache classification of the International Headache Society. Cephalalgia 14(2):97–106
Article
CAS
PubMed
Google Scholar
Henry P, Michel P, Brochet B, Dartigues JF, Tison S, Salamon R (1992) A nationwide survey of migraine in France: prevalence and clinical features in adults. GRIM. Cephalalgia 12(4):229–237, discussion 186
Article
CAS
PubMed
Google Scholar
Antonaci F, Ghiotto N, Wu S, Pucci E, Costa A (2016) Recent advances in migraine therapy. Springerplus 5:637
Article
PubMed
PubMed Central
CAS
Google Scholar
Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E (2012) Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 78(17):1337–1345
Article
CAS
PubMed
PubMed Central
Google Scholar
Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A et al (2009) EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol 16(9):968–981
Article
CAS
PubMed
Google Scholar
Marmura MJ, Silberstein SD, Schwedt TJ (2015) The acute treatment of migraine in adults: the american headache society evidence assessment of migraine pharmacotherapies. Headache 55(1):3–20
Article
PubMed
Google Scholar
Pringsheim T, Davenport WJ, Marmura MJ, Schwedt TJ, Silberstein S (2016) How to apply the AHS evidence assessment of the acute treatment of migraine in adults to your patient with migraine. Headache 56(7):1194–1200
Article
PubMed
Google Scholar
Diamond ML, Hettiarachchi J, Hilliard B, Sands G, Nett R (2004) Effectiveness of eletriptan in acute migraine: primary care for Excedrin nonresponders. Headache 44(3):209–216
Article
PubMed
Google Scholar
Pascual J, Cabarrocas X (2002) Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better. Headache 42(1):28–31
Article
PubMed
Google Scholar
Dowson AJ, Massiou H, Lainez JM, Cabarrocas X (2004) Almotriptan improves response rates when treatment is within 1 hour of migraine onset. Headache 44(4):318–322
Article
CAS
PubMed
Google Scholar
Burstein R, Collins B, Jakubowski M (2004) Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 55(1):19–26
Article
CAS
PubMed
Google Scholar
Linde M, Mellberg A, Dahlof C (2006) Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack. Cephalalgia 26(2):113–121
Article
CAS
PubMed
Google Scholar
(1999) Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group. Cephalalgia 19(4):232–240
Ahrens SP, Farmer MV, Williams DL, Willoughby E, Jiang K, Block GA et al (1999) Efficacy and safety of rizatriptan wafer for the acute treatment of migraine. Cephalalgia 19(5):525–530
Article
CAS
PubMed
Google Scholar
Barbanti P, Carpay JA, Kwong WJ, Ahmad F, Boswell D (2004) Effects of a fast disintegrating/rapid release oral formulation of sumatriptan on functional ability in patients with migraine. Curr Med Res Opin 20(12):2021–2029
Article
CAS
PubMed
Google Scholar
Bomhof M, Paz J, Legg N, Allen C, Vandormael K, Patel K (1999) Comparison of rizatriptan 10 mg vs. naratriptan 2.5 mg in migraine. Eur Neurol 42(3):173–179
Article
CAS
PubMed
Google Scholar
Bousser MG, D’Allens H, Richard A (1993) Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group. J Intern Med 234(2):211–216
Article
CAS
PubMed
Google Scholar
Brandes JL, Kudrow D, Stark SR, O’Carroll CP, Adelman JU, O’Donnell FJ et al (2007) Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA 297(13):1443–1454
Article
CAS
PubMed
Google Scholar
Bussone G, Manzoni GC, Cortelli P, Roncolato M, Fabbri L, Benassuti C (2000) Efficacy and tolerability of sumatriptan in the treatment of multiple migraine attacks. Neurol Sci 21(5):272–278
Article
CAS
PubMed
Google Scholar
Cady RC, Ryan R, Jhingran P, O’Quinn S, Pait DG (1998) Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial. Arch Intern Med 158(9):1013–1018
Article
CAS
PubMed
Google Scholar
Carleton SC, Shesser RF, Pietrzak MP, Chudnofsky CR, Starkman S, Morris DL et al (1998) Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache. Ann Emerg Med 32(2):129–138
Article
CAS
PubMed
Google Scholar
Charlesworth BR, Dowson AJ, Purdy A, Becker WJ, Boes-Hansen S, Farkkila M (2003) Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet. CNS Drugs 17(9):653–667
Article
CAS
PubMed
Google Scholar
Codispoti JR, Prior MJ, Fu M, Harte CM, Nelson EB (2001) Efficacy of nonprescription doses of ibuprofen for treating migraine headache. A randomized controlled trial. Headache 41(7):665–679
Article
CAS
PubMed
Google Scholar
Dahlof C, Diener HC, Goadsby PJ, Massiou H, Olesen J, Schoenen J et al (1998) Zolmitriptan, a 5-HT1B/1D receptor agonist for the acute oral treatment of migraine: a multicentre, dose-range finding study. Eur J Neurol 5(6):535–543
Article
PubMed
Google Scholar
Dahlof C, Hogenhuis L, Olesen J, Petit H, Ribbat J, Schoenen J et al (1998) Early clinical experience with subcutaneous naratriptan in the acute treatment of migraine: a dose-ranging study. Eur J Neurol 5(5):469–477
Article
PubMed
Google Scholar
Diamond S, Elkind A, Jackson RT, Ryan R, DeBussey S, Asgharnejad M (1998) Multiple-attack efficacy and tolerability of sumatriptan nasal spray in the treatment of migraine. Arch Fam Med 7(3):234–240
Article
CAS
PubMed
Google Scholar
Diener HC (1999) Efficacy and safety of intravenous acetylsalicylic acid lysinate compared to subcutaneous sumatriptan and parenteral placebo in the acute treatment of migraine. A double-blind, double-dummy, randomized, multicenter, parallel group study. The ASASUMAMIG Study Group. Cephalalgia 19(6):581–588, discussion 542
Article
CAS
PubMed
Google Scholar
Diener HC, Bussone G, De Liano H, Eikermann A, Englert R, Floeter T et al (2004) Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks. Cephalalgia 24(11):947–954
Article
CAS
PubMed
Google Scholar
Diener HC, Eikermann A, Gessner U, Gobel H, Haag G, Lange R et al (2004) Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms. Eur Neurol 52(1):50–56
Article
CAS
PubMed
Google Scholar
Diener HC, Gendolla A, Gebert I, Beneke M (2005) Almotriptan in migraine patients who respond poorly to oral sumatriptan: a double-blind, randomized trial. Eur Neurol 53(Suppl 1):41–48
Article
CAS
PubMed
Google Scholar
Diener HC, Jansen JP, Reches A, Pascual J, Pitei D, Steiner TJ (2002) Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison. Eur Neurol 47(2):99–107
Article
PubMed
Google Scholar
Diener HC, Montagna P, Gács G, Lyczak P, Schumann G, Zöller B et al (2006) Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo. Cephalalgia 26(5):537–547
Article
PubMed
Google Scholar
Djupesland PG, Docekal P (2010) Intranasal sumatriptan powder delivered by a novel breath-actuated bi-directional device for the acute treatment of migraine: a randomised, placebo-controlled study. Cephalalgia 30(8):933–942
CAS
PubMed
Google Scholar
Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L (2005) Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study. CNS Drugs 19(2):125–136
Article
CAS
PubMed
Google Scholar
Dodick DW (2002) Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials. Headache 42(1):21–27
Article
PubMed
Google Scholar
Dowson A, Ball K, Haworth D (2000) Comparison of a fixed combination of domperidone and paracetamol (Domperamol) with sumatriptan 50 mg in moderate to severe migraine: a randomised UK primary care study. Curr Med Res Opin 16(3):190–197
Article
CAS
PubMed
Google Scholar
Dowson AJ, MacGregor EA, Purdy RA, Becker WJ, Green J, Levy SL (2002) Zolmitriptan orally disintegrating tablet is effective in the acute treatment of migraine. Cephalalgia 22(2):101–106
Article
CAS
PubMed
Google Scholar
Dowson AJ, Massiou H, Lainez JM, Cabarrocas X (2002) Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial. Cephalalgia 22(6):453–461
Article
CAS
PubMed
Google Scholar
Freitag F, Diamond M, Diamond S, Janssen I, Rodgers A, Skobieranda F (2008) Efficacy and tolerability of coadministration of rizatriptan and acetaminophen vs rizatriptan or acetaminophen alone for acute migraine treatment. Headache 48(6):921–930
Article
PubMed
Google Scholar
Gallagher RM, Dennish G, Spierings EL, Chitra R (2000) A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine. Headache 40(2):119–128
Article
CAS
PubMed
Google Scholar
Gawel M, Aschoff J, May A, Charlesworth BR (2005) Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study. Headache 45(1):7–16
Article
PubMed
Google Scholar
Geraud G, Compagnon A, Rossi A (2002) Zolmitriptan versus a combination of acetylsalicylic acid and metoclopramide in the acute oral treatment of migraine: a double-blind, randomised, three-attack study. Eur Neurol 47(2):88–98
Article
CAS
PubMed
Google Scholar
Geraud G, Olesen J, Pfaffenrath V, Tfelt-Hansen P, Zupping R, Diener HC et al (2000) Comparison of the efficacy of zolmitriptan and sumatriptan: issues in migraine trial design. Cephalalgia 20(1):30–38
Article
CAS
PubMed
Google Scholar
Goadsby PJ, Massiou H, Pascual J, Diener HC, Dahlof CG, Mateos V et al (2007) Almotriptan and zolmitriptan in the acute treatment of migraine. Acta Neurol Scand 115(1):34–40
Article
CAS
PubMed
Google Scholar
Gobel H, Winter P, Boswell D, Crisp A, Becker W, Hauge T et al (2000) Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group. Clin Ther 22(8):981–989
Article
CAS
PubMed
Google Scholar
Goldstein J, Ryan R, Jiang K, Getson A, Norman B, Block GA et al (1998) Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group. Headache 38(10):737–747
Article
CAS
PubMed
Google Scholar
Goldstein J, Silberstein SD, Saper JR, Elkind AH, Smith TR, Gallagher RM et al (2005) Acetaminophen, aspirin, and caffeine versus sumatriptan succinate in the early treatment of migraine: results from the ASSET trial. Headache 45(8):973–982
Article
PubMed
Google Scholar
Goldstein J, Silberstein SD, Saper JR, Ryan RE Jr, Lipton RB (2006) Acetaminophen, aspirin, and caffeine in combination versus ibuprofen for acute migraine: results from a multicenter, double-blind, randomized, parallel-group, single-dose, placebo-controlled study. Headache 46(3):444–453
Article
PubMed
Google Scholar
Gross ML, Kay J, Turner AM, Hallett K, Cleal AL, Hassani H (1994) Sumatriptan in acute migraine using a novel cartridge system self-injector. United Kingdom Study Group. Headache 34(10):559–563
Article
CAS
PubMed
Google Scholar
Gruffyd-Jones K, Kies B, Middleton A, Mulder LJ, Rosjo O, Millson DS (2001) Zolmitriptan versus sumatriptan for the acute oral treatment of migraine: a randomized, double-blind, international study. Eur J Neurol 8(3):237–245
Article
CAS
PubMed
Google Scholar
Havanka H, Dahlof C, Pop PH, Diener HC, Winter P, Whitehouse H et al (2000) Efficacy of naratriptan tablets in the acute treatment of migraine: a dose-ranging study. Naratriptan S2WB2004 Study Group. Clin Ther 22(8):970–980
Article
CAS
PubMed
Google Scholar
Henry P, d’Allens H (1993) Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble. Headache 33(8):432–435
Article
CAS
PubMed
Google Scholar
Jelinski SE, Becker WJ, Christie SN, Ahmad FE, Pryse-Phillips W, Simpson SD (2006) Pain free efficacy of sumatriptan in the early treatment of migraine. Can J Neurol Sci 33(1):73–79
Article
PubMed
Google Scholar
Kellstein DE, Lipton RB, Geetha R, Koronkiewicz K, Evans FT, Stewart WF et al (2000) Evaluation of a novel solubilized formulation of ibuprofen in the treatment of migraine headache: a randomized, double-blind, placebo-controlled, dose-ranging study. Cephalalgia 20(4):233–243
Article
CAS
PubMed
Google Scholar
Klapper J, Lucas C, Rosjo O, Charlesworth B (2004) Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild. Cephalalgia 24(11):918–924
Article
CAS
PubMed
Google Scholar
Kolodny A, Polis A, Battisti WP, Johnson-Pratt L, Skobieranda F (2004) Comparison of rizatriptan 5 mg and 10 mg tablets and sumatriptan 25 mg and 50 mg tablets. Cephalalgia 24(7):540–546
Article
CAS
PubMed
Google Scholar
Lange R, Schwarz JA, Hohn M (2000) Acetylsalicylic acid effervescent 1000 mg (Aspirin) in acute migraine attacks; a multicentre, randomized, double-blind, single-dose, placebo-controlled parallel group study. Cephalalgia 20(7):663–667
CAS
PubMed
Google Scholar
Le Jeunne C, Gomez JP, Pradalier A, Titus i Albareda F, Joffroy A, Liano H et al (1999) Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks. Eur Neurol 41(1):37–43
Article
PubMed
Google Scholar
Lewis DW, Kellstein D, Dahl G, Burke B, Frank LM, Toor S et al (2002) Children’s ibuprofen suspension for the acute treatment of pediatric migraine. Headache 42(8):780–786
Article
PubMed
Google Scholar
Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M (2000) Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study. Arch Intern Med 160(22):3486–3492
Article
CAS
PubMed
Google Scholar
Lipton RB, Goldstein J, Baggish JS, Yataco AR, Sorrentino JV, Quiring JN (2005) Aspirin is efficacious for the treatment of acute migraine. Headache 45(4):283–292
Article
PubMed
Google Scholar
Lipton RB, Grosberg B, Singer RP, Pearlman SH, Sorrentino JV, Quiring JN et al (2010) Efficacy and tolerability of a new powdered formulation of diclofenac potassium for oral solution for the acute treatment of migraine: results from the International Migraine Pain Assessment Clinical Trial (IMPACT). Cephalalgia 30(11):1336–1345
Article
PubMed
Google Scholar
Lipton RB, Stewart WF, Cady R, Hall C, O’Quinn S, Kuhn T et al (2000) Sumatriptan for the range of headaches in migraine sufferers: results of the spectrum study. Headache 40(10):783–791
Article
CAS
PubMed
Google Scholar
Loder E, Freitag FG, Adelman J, Pearlmand S, Abu-Shakra S (2005) Pain-free rates with zolmitriptan 2.5 mg ODT in the acute treatment of migraine: results of a large double-blind placebo- controlled trial. Curr Med Res Opin 21(3):381–389
Article
CAS
PubMed
Google Scholar
MacGregor EA, Dowson A, Davies PT (2002) Mouth-dispersible aspirin in the treatment of migraine: a placebo-controlled study. Headache 42(4):249–255
Article
PubMed
Google Scholar
Mannix LK, Loder E, Nett R, Mueller L, Rodgers A, Hustad CM et al (2007) Rizatriptan for the acute treatment of ICHD-II proposed menstrual migraine: two prospective, randomized, placebo-controlled, double-blind studies. Cephalalgia 27(5):414–421
Article
CAS
PubMed
Google Scholar
Mannix LK, Martin VT, Cady RK, Diamond ML, Lener SE, White JD et al (2009) Combination treatment for menstrual migraine and dysmenorrhea using sumatriptan-naproxen: two randomized controlled trials. Obstet Gynecol 114(1):106–113
Article
PubMed
Google Scholar
Mathew NT, Finlayson G, Smith TR, Cady RK, Adelman J, Mao L et al (2007) Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study). Headache 47(2):189–198
Article
PubMed
Google Scholar
Mathew NT, Schoenen J, Winner P, Muirhead N, Sikes CR (2003) Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg. Headache 43(3):214–222
Article
PubMed
Google Scholar
Misra UK, Jose M, Kalita J (2004) Rofecoxib versus ibuprofen for acute treatment of migrainne: a randomised placebo controlled trial. Postgrad Med J 80(950):720–723
Article
CAS
PubMed
PubMed Central
Google Scholar
Misra UK, Kalita J, Yadav RK (2007) Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial. J Headache Pain 8(3):175–179
Article
CAS
PubMed
PubMed Central
Google Scholar
Myllyla VV, Havanka H, Herrala L, Kangasniemi P, Rautakorpi I, Turkka J et al (1998) Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: comparable effect in a double-blind, randomized, controlled, parallel-group study. Headache 38(3):201–207
Article
CAS
PubMed
Google Scholar
Nappi G, Sicuteri F, Byrne M, Roncolato M, Zerbini O (1994) Oral sumatriptan compared with placebo in the acute treatment of migraine. J Neurol 241(3):138–144
Article
CAS
PubMed
Google Scholar
Pascual J, Falk RM, Piessens F, Prusinski A, Docekal P, Robert M et al (2000) Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: results of a large, randomized, double-blind, placebo-controlled study. Cephalalgia 20(6):588–596
Article
CAS
PubMed
Google Scholar
Pascual J, Vega P, Diener HC, Allen C, Vrijens F, Patel K (2000) Comparison of rizatriptan 10 mg vs. zolmitriptan 2.5 mg in the acute treatment of migraine. Rizatriptan-Zolmitriptan Study Group. Cephalalgia 20(5):455–461
Article
CAS
PubMed
Google Scholar
Peikert A, Becker WJ, Ashford EA, Dahlof C, Hassani H, Salonen RJ (1999) Sumatriptan nasal spray: a dose-ranging study in the acute treatment of migraine. Eur J Neurol 6(1):43–49
Article
CAS
PubMed
Google Scholar
Peroutka SJ, Lyon JA, Swarbrick J, Lipton RB, Kolodner K, Goldstein J (2004) Efficacy of diclofenac sodium softgel 100 mg with or without caffeine 100 mg in migraine without aura: a randomized, double-blind, crossover study. Headache 44(2):136–141
Article
PubMed
Google Scholar
Pfaffenrath V, Cunin G, Sjonell G, Prendergast S (1998) Efficacy and safety of sumatriptan tablets (25 mg, 50 mg, and 100 mg) in the acute treatment of migraine: defining the optimum doses of oral sumatriptan. Headache 38(3):184–190
Article
CAS
PubMed
Google Scholar
Rothner AD, Wasiewski W, Winner P, Lewis D, Stankowski J (2006) Zolmitriptan oral tablet in migraine treatment: high placebo responses in adolescents. Headache 46(1):101–109
Article
PubMed
Google Scholar
Ryan RE Jr, Diamond S, Giammarco RAM, Aurora SK, Reed RC, Fletcher PE (2000) Efficacy of Zolmitriptan at early time-points for the acute treatment of migraine and treatment of recurrence: a randomised, placebo-controlled trial. CNS Drugs 13(3):215–226
Article
CAS
Google Scholar
Sakai F, Iwata M, Tashiro K, Itoyama Y, Tsuji S, Fukuuchi Y et al (2002) Zolmitriptan is effective and well tolerated in Japanese patients with migraine: a dose–response study. Cephalalgia 22(5):376–383
Article
CAS
PubMed
Google Scholar
Salonen R, Ashford E, Dahlof C, Dawson R, Gilhus NE, Luben V et al (1994) Intranasal sumatriptan for the acute treatment of migraine. International Intranasal Sumatriptan Study Group. J Neurol 241(8):463–469
Article
CAS
PubMed
Google Scholar
Scherl ER, Wilson JF (1995) Comparison of dihydroergotamine with metoclopramide versus meperidine with promethazine in the treatment of acute migraine. Headache 35(5):256–259
Article
CAS
PubMed
Google Scholar
Schulman EA, Cady RK, Henry D, Batenhorst AS, Putnam DG, Watson CB et al (2000) Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial. Mayo Clin Proc 75(8):782–789
Article
CAS
PubMed
Google Scholar
Schulman EA, Dermott KF (2003) Sumatriptan plus metoclopramide in triptan-nonresponsive migraineurs. Headache 43(7):729–733
Article
PubMed
Google Scholar
Sheftell FD, Dahlof CG, Brandes JL, Agosti R, Jones MW, Barrett PS (2005) Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Clin Ther 27(4):407–417
Article
CAS
PubMed
Google Scholar
Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ (2005) Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache 45(8):983–991
Article
PubMed
Google Scholar
Spierings EL, Gomez-Mancilla B, Grosz DE, Rowland CR, Whaley FS, Jirgens KJ (2001) Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison. Arch Neurol 58(6):944–950
Article
CAS
PubMed
Google Scholar
Spierings EL, Rapoport AM, Dodick DW, Charlesworth B (2004) Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet. CNS Drugs 18(15):1133–1141
Article
CAS
PubMed
Google Scholar
Steiner TJ, Diener HC, MacGregor EA, Schoenen J, Muirheads N, Sikes CR (2003) Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine. Cephalalgia 23(10):942–952
Article
CAS
PubMed
Google Scholar
Teall J, Tuchman M, Cutler N, Gross M, Willoughby E, Smith B et al (1998) Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Headache 38(4):281–287
Article
CAS
PubMed
Google Scholar
Tepper SJ, Donnan GA, Dowson AJ, Bomhof MA, Elkind A, Meloche J et al (1999) A long-term study to maximise migraine relief with zolmitriptan. Curr Med Res Opin 15(4):254–271
Article
CAS
PubMed
Google Scholar
Tfelt-Hansen P, Henry P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G (1995) The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 346(8980):923–926
Article
CAS
PubMed
Google Scholar
Tfelt-Hansen P, Teall J, Rodriguez F, Giacovazzo M, Paz J, Malbecq W et al (1998) Oral rizatriptan versus oral sumatriptan: a direct comparative study in the acute treatment of migraine. Rizatriptan 030 Study Group. Headache 38(10):748–755
Article
CAS
PubMed
Google Scholar
Touchon J, Bertin L, Pilgrim AJ, Ashford E, Bes A (1996) A comparison of subcutaneous sumatriptan and dihydroergotamine nasal spray in the acute treatment of migraine. Neurology 47(2):361–365
Article
CAS
PubMed
Google Scholar
Tullo V, Allais G, Ferrari MD, Curone M, Mea E, Omboni S et al (2010) Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study. Neurol Sci 31(Suppl 1):S51–S54
Article
PubMed
Google Scholar
Wang SJ, Fuh JL, Wu ZA (2007) Intranasal sumatriptan study with high placebo response in Taiwanese patients with migraine. J Chin Med Assoc 70(2):39–46
Article
CAS
PubMed
Google Scholar
Wendt J, Cady R, Singer R, Peters K, Webster C, Kori S et al (2006) A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Clin Ther 28(4):517–526
Article
CAS
PubMed
Google Scholar
Winner P, Mannix LK, Putnam DG, McNeal S, Kwong J, O’Quinn S et al (2003) Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies. Mayo Clin Proc 78(10):1214–1222
Article
CAS
PubMed
Google Scholar
Capi M, Curto M, Lionetto L, de Andres F, Gentile G, Negro A et al (2016) Eletriptan in the management of acute migraine: an update on the evidence for efficacy, safety, and consistent response. Ther Adv Neurol Disord 9(5):414–423
Article
CAS
PubMed
PubMed Central
Google Scholar
Lionetto L, Casolla B, Mastropietri F, D’Alonzo L, Negro A, Simmaco M et al (2012) Pharmacokinetic evaluation of zolmitriptan for the treatment of migraines. Expert Opin Drug Metab Toxicol 8(8):1043–1050
Article
CAS
PubMed
Google Scholar
Napoletano F, Lionetto L, Martelletti P (2014) Sumatriptan in clinical practice: effectiveness in migraine and the problem of psychiatric comorbidity. Expert Opin Pharmacother 15(3):303–305
Article
CAS
PubMed
Google Scholar
Cameron C, Kelly S, Hsieh SC, Murphy M, Chen L, Kotb A et al (2015) Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache 55(Suppl 4):221–235
Article
PubMed
Google Scholar
Napier C, Stewart M, Melrose H, Hopkins B, McHarg A, Wallis R (1999) Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. Eur J Pharmacol 368(2–3):259–268
Article
CAS
PubMed
Google Scholar
Knyihar-Csillik E, Tajti J, Csillik AE, Chadaide Z, Mihaly A, Vecsei L (2000) Effects of eletriptan on the peptidergic innervation of the cerebral dura mater and trigeminal ganglion, and on the expression of c-fos and c-jun in the trigeminal complex of the rat in an experimental migraine model. Eur J Neurosci 12(11):3991–4002
Article
CAS
PubMed
Google Scholar
Johnson DE, Rollema H, Schmidt AW, McHarg AD (2001) Serotonergic effects and extracellular brain levels of eletriptan, zolmitriptan and sumatriptan in rat brain. Eur J Pharmacol 425(3):203–210
Article
CAS
PubMed
Google Scholar
Patrono C, Patrignani P, Garcia Rodriguez LA (2001) Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J Clin Invest 108(1):7–13
Article
CAS
PubMed
PubMed Central
Google Scholar
Patrono C, Baigent C (2009) Low-dose aspirin, coxibs, and other NSAIDS: a clinical mosaic emerges. Mol Interv 9(1):31–39
Article
CAS
PubMed
Google Scholar
Goadsby PJ, Lipton RB, Ferrari MD (2002) Migraine--current understanding and treatment. N Engl J Med 346(4):257–270
Article
CAS
PubMed
Google Scholar
Burstein R, Cutrer MF, Yarnitsky D (2000) The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 123(Pt 8):1703–1709
Article
PubMed
Google Scholar
Burstein R (2001) Deconstructing migraine headache into peripheral and central sensitization. Pain 89(2–3):107–110
Article
CAS
PubMed
Google Scholar
Loo CY, Tan HJ, Teh HS, Raymond AA (2007) Randomised, open label, controlled trial of celecoxib in the treatment of acute migraine. Singapore Med J 48(9):834–839
CAS
PubMed
Google Scholar
Krymchantowski AV, Bigal ME (2004) Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. BMC Neurol 4:10
Article
PubMed
PubMed Central
CAS
Google Scholar
Krymchantowski AV, Barbosa JS (2002) Rizatriptan combined with rofecoxib vs. rizatriptan for the acute treatment of migraine: an open label pilot study. Cephalalgia 22(4):309–312
Article
CAS
PubMed
Google Scholar